These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18181578)

  • 1. Changing requirements of purification as drug discovery programs evolve from hit discovery.
    Isbell J
    J Comb Chem; 2008; 10(2):150-7. PubMed ID: 18181578
    [No Abstract]   [Full Text] [Related]  

  • 2. Supercritical fluid chromatography and steady-state recycling: phase appropriate technologies for the resolutions of pharmaceutical intermediates in the early drug development stage.
    Yan TQ; Orihuela C; Preston JP; Xia F
    Chirality; 2010 Nov; 22(10):922-8. PubMed ID: 20872668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
    Lin M; Tesconi M; Tischler M
    Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
    Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
    Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparative chromatographic resolution of racemates using HPLC and SFC in a pharmaceutical discovery environment.
    Miller L; Potter M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(1):230-6. PubMed ID: 18639504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery.
    Kennedy D
    Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular medicine. NIH dives into drug discovery.
    Couzin J
    Science; 2003 Oct; 302(5643):218-21. PubMed ID: 14551416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methods of pharmaceutical analysis: analysis of information flow].
    Subert J; Blesová M
    Pharmazie; 1976; 31(9):624-7. PubMed ID: 1019210
    [No Abstract]   [Full Text] [Related]  

  • 12. High throughput screening of active pharmaceutical ingredients by UPLC.
    Al-Sayah MA; Rizos P; Antonucci V; Wu N
    J Sep Sci; 2008 Jul; 31(12):2167-72. PubMed ID: 18563754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of a multi-detection system composed of ultraviolet, evaporative light scattering and inductively coupled plasma mass spectrometry detection for the analysis of pharmaceuticals by liquid chromatography.
    Pereira AS; Schelfaut M; Lynen F; Sandra P
    J Chromatogr A; 2008 Mar; 1185(1):78-84. PubMed ID: 18262535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit and Lead identification: efficient practices for drug discovery.
    Goodnow RA; Gillespie P
    Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
    [No Abstract]   [Full Text] [Related]  

  • 15. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analytical methods in the control of pharmaceutical preparations].
    De Santis A; Fabris L; Fontani F; Zorzetto C
    Boll Chim Farm; 1971 Mar; 110(3):127-31. PubMed ID: 5561773
    [No Abstract]   [Full Text] [Related]  

  • 17. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.
    Görög S; Balogh G; Csehi A; Csizér E; Gazdag M; Halmos Z; Hegedüs B; Herényi B; Horváth P; Laukó A
    J Pharm Biomed Anal; 1993; 11(11-12):1219-26. PubMed ID: 8123737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous counter-current extraction on an industrial sample using dual-flow counter-current chromatography.
    van den Heuvel R; Mathews B; Dubant S; Sutherland I
    J Chromatogr A; 2009 May; 1216(19):4147-53. PubMed ID: 19211107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of parallel chemistry in drug discovery.
    Edwards PJ
    IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.